By Shi Bisheng, Guan Xiangyu,King & Wood Mallesons’ IP group

In October 2017, the China Food and Drug Administration (“CFDA”) released a series of documents regarding reform of China’s drug administration system. The aim – more access to cutting-edge pharmaceuticals at a lower cost. This new patent linkage system (“PLS”) is discussed in the following two important documents:
Continue Reading How to Rise Up to Challenges under Accelerated Enforcement of Patent Linkage